Inhibition of IRAK1/4 enhances the antitumor effect of lenvatinib in anaplastic thyroid cancer cells

Yoshifumi Kawamura, Ken Saijo, Hiroo Imai, Chikashi Ishioka

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Inhibition of IRAK1/4 enhances the antitumor effect of lenvatinib in anaplastic thyroid cancer cells'. Together they form a unique fingerprint.

Medicine & Life Sciences